Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Prostate Cancer”

113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 113 results

Large-scale testing (Phase 3)Looking for participantsNCT04794777
What this trial is testing

Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer

Who this might be right for
Prostate Cancer
Stefan Carlsson 450
Early research (Phase 1)Study completedNCT01949519
What this trial is testing

Docetaxel and Lycopene in Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Medical University of South Carolina 24
Early research (Phase 1)Ended earlyNCT00848601
What this trial is testing

Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma

Who this might be right for
Prostate CancerNon-Hodgkins Lymphoma
Astex Pharmaceuticals, Inc. 14
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04536805
What this trial is testing

Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin

Who this might be right for
Prostate Cancer
Institut Cancerologie de l'Ouest 44
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Not applicableActive Not RecruitingNCT01492751
What this trial is testing

Effectiveness of Localized Prostate Cancer Treatments

Who this might be right for
Prostate Cancer
Fundacion IMIM 500
Large-scale testing (Phase 3)Study completedNCT03009981
What this trial is testing

Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance Foundation Trials, LLC. 504
Not applicableStudy completedNCT02920229
What this trial is testing

68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated

Who this might be right for
68Ga-PSMA HBED-PET/CTProstate Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 1,230
Testing effectiveness (Phase 2)Study completedNCT00454571
What this trial is testing

Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer

Who this might be right for
Recurrent Prostate Cancer
National Cancer Institute (NCI) 37
Large-scale testing (Phase 3)Study completedNCT00667069
What this trial is testing

Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 424
Not applicableEnded earlyNCT05709535
What this trial is testing

PSMA-PET/CT Registry

Who this might be right for
Prostate Cancer
AHS Cancer Control Alberta 128
Testing effectiveness (Phase 2)Ended earlyNCT00879619
What this trial is testing

Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer+3 more
John P. Fruehauf 4
Testing effectiveness (Phase 2)Ended earlyNCT04635059
What this trial is testing

Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate Cancer

Who this might be right for
Prostate Cancer
Medical College of Wisconsin 6
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableActive Not RecruitingNCT03630666
What this trial is testing

Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients

Who this might be right for
Prostate CancerOligometastasis
Institut Cancerologie de l'Ouest 256
Not applicableEnded earlyNCT01100866
What this trial is testing

Study of POMELLA™ Extract to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Vancouver Coastal Health 1
Testing effectiveness (Phase 2)Study completedNCT00069888
What this trial is testing

A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy

Who this might be right for
Prostate Cancer
Sanofi 83
Early research (Phase 1)Ended earlyNCT02875223
What this trial is testing

A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinNeoplasms
Celgene 75
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Next Page